Literature DB >> 29265730

Powerful diuretics: A common denominator in landmark hypertension and type 2 diabetes mellitus trials.

Kaberi Dasgupta1, Ruth Sapir-Pichhadze1, Nadia Khan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29265730      PMCID： PMC8030921          DOI： 10.1111/jch.13151

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  44 in total

1.  Diet and diuretics in the treatment of hypertensive cardiovascular disease.

Authors:  H P DUSTAN
Journal:  J Am Med Assoc       Date:  1960-04-30

Review 2.  Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2006-09       Impact factor: 1.636

3.  Treatment of hypertensive vascular disease with rice diet.

Authors:  W KEMPNER
Journal:  Am J Med       Date:  1948-04       Impact factor: 4.965

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  The Veterans Administration cooperative study on antihypertensive agents. Implications for stroke prevention.

Authors:  E D Freis
Journal:  Stroke       Date:  1974 Jan-Feb       Impact factor: 7.914

6.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

7.  Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.

Authors:  Ilkka Tikkanen; Kirsi Narko; Cordula Zeller; Alexandra Green; Afshin Salsali; Uli C Broedl; Hans J Woerle
Journal:  Diabetes Care       Date:  2014-09-30       Impact factor: 19.112

Review 8.  Diuretics for Hypertension: A Review and Update.

Authors:  George C Roush; Domenic A Sica
Journal:  Am J Hypertens       Date:  2016-04-05       Impact factor: 2.689

9.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Eva M Lonn; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Lisheng Liu; Prem Pais; Rafael Diaz; Denis Xavier; Karen Sliwa; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Katalin Keltai; Matyas Keltai; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Alexander Parkhomenko; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Lawrence A Leiter; Dora I Molina; Robert McKelvie; Janice Pogue; Joanne Wilkinson; Hyejung Jung; Gilles Dagenais; Salim Yusuf
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

10.  Powerful diuretics: A common denominator in landmark hypertension and type 2 diabetes mellitus trials.

Authors:  Kaberi Dasgupta; Ruth Sapir-Pichhadze; Nadia Khan
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-18       Impact factor: 3.738
View more
  1 in total

1.  Powerful diuretics: A common denominator in landmark hypertension and type 2 diabetes mellitus trials.

Authors:  Kaberi Dasgupta; Ruth Sapir-Pichhadze; Nadia Khan
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-18       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.